EC Gynaecology

Editorial Volume 12 Issue 8 - 2023

Escape Ovulation in HRT-Frozen Embryo Transfer Cycles and Use of Gn-RH Antagonists-An Opinion

Rafet Gazvani*, MD, FRCOG

Consultant Gynaecologist, Subspecialist in Reproductive Medicine and Surgery, Liverpool Women’s Hospital, Crown Street, Liverpool, United Kingdom

*Corresponding Author: Rafet Gazvani, Consultant Gynaecologist, Subspecialist in Reproductive Medicine and Surgery, Liverpool Women’s Hospital, Crown Street, Liverpool, United Kingdom.
Received: July 23, 2023; Published: July 27, 2023



Stimulated frozen embryo transfer cycles (FET), also called hormone replacement (HRT) FET cycles, utilise a high dose of oestrogen from the start of a natural menstrual cycle. This helps to build the endometrium and suppress ovulation. Suppression of ovulation is caused by suppressing follicle-stimulating hormone (FSH) and luteinising hormone (LH) from the anterior pituitary. Escape ovulation, which is unexpected follicular development in HRT-FET, is uncommon but an event that happens on a regular basis. This inevitably influences the timing of the embryo transfer hence the outcomes.

Escape ovulation is an event which can be encountered in 1.9 - 7.4% of HRT-FET cycles without pituitary suppression [1] either with gonadotrophin agonists (GnRH-a) or antagonists. If recognised, escape ovulation leads to the cancellation of the treatment. If unrecognised, however, it would directly affect the outcome and influence the pregnancy rates due to possible mistiming of the embryo transfer (ET). Recognising or avoiding escape ovulation may therefore improve the outcomes in HRT-FET cycles.

Rafet Gazvani. Escape Ovulation in HRT-Frozen Embryo Transfer Cycles and Use of Gn-RH Antagonists-An Opinion. EC Gynaecology 12.8 (2023): 01-02.